Elyse Park, PhD, speaks about the ASCO 2022 abstract, “A health insurance navigation intervention tool (HINT) for survivors of childhood cancer: Randomized pilot trial results from the Childhood Cancer Survivor Study”

HPRIR Director, Elyse Park, PhD, speaks with Oncology Tube about the ASCO ’22 abstract, “A health insurance navigation intervention tool (HINT) for survivors of childhood cancer: randomized pilot trial results from the Childhood Cancer Survivor Study.” Summary: The Childhood Cancer Survivor Study (CCSS) will look into the long-term impact of Read more…

HPRIR Director, Elyse Park, PhD, Speaks for the 2022 Gold Together Champions for Childhood Cancer Kickoff

The National Gold Together Champions Campaign brings awareness and funding to childhood cancer in the month of September, childhood cancer awareness month! This Zoom kickoff covers why families facing childhood cancer need our support and how we can make an impact. HPRIR Director, Elyse Park, PhD, shares her ACS funded Read more…

Daniel Hall, PhD, and Zach Wallace, MD, interviewed by the EIC of The Journal of Rheumatology

Editor-in-Chief of the Journal of Rheumatology, Dr. Earl Silverman, speaks with Daniel L. Hall and Zachary S. Wallace about their article “The Association of Illness-related Uncertainty With Mental Health in Systemic Autoimmune Rheumatic Diseases.” You can watch the interview here – https://www.jrheum.org/content/viewingrheum For the full article: The Association of Illness-related Uncertainty With Mental Read more…

Efren Flores, MD, selected to the CMSS-NAM-WHO Advisory Board for Identifying Credible Sources of Health Information in Social Media

Congratulations to HPRIR faculty member, Efren Flores, MD, on his selection to the Council of Medical Specialty Services (CMSS)-National Academy of Medicine (NAM)-World Health Organization (WHO) Advisory Board. This distinguished and diverse group of experts will guide the development of a globally relevant, expanded set of principles applicable to potential Read more…

Dr. Giselle Lougee-Perez, PhD selected to participate in the Secondary Mentorship Program for Diverse Research Faculty

Congratulations to Giselle Lougee-Perez, Ph.D., who was selected to participate in the MGH Disparities Solutions Center Secondary Mentorship Program for Diverse Research Faculty. This one-year Pilot Program begins late June 2022 and will continue through June 2023. The Program pairs 4 junior faculty members, at MGH, from historically under-represented groups, Read more…

Dr. Angela Walter Presents on Neighborhood Disadvantage and Tobacco Use Among Cancer Patients at ASCO

Dr. Angela Walter presented on neighborhood disadvantage and tobacco use among adults with cancer in the U.S. at the 2022 American Society of Clinical Oncology [ASCO] Annual Meeting in Chicago. The results Dr. Walter presented span 10 ECOG-ACRIN trials which found that socioeconomic factors influence access and utilization of tobacco Read more…

Brett Goshe, Ph.D., presents EAQ171CD (SSS2) trial updates at the ECOG-ACRIN Annual Conference in Chicago!

Last week, at the ECOG-ACRIN Cancer Research Group annual conference, project director Dr. Brett Goshe (pictured above) presented trial updates for the EAQ171CD Smoke Free Support Study 2.0. The Smoke Free Support Study 2.0 is a trial designed to examine the effectiveness and implementation of a virtually-delivered, evidence-based tobacco treatment Read more…

Dr. Amy Comander runs the Boston Marathon in support of the Ellie Fund!

Breast Oncologist and HPRIR-collaborator, Dr. Amy Comander, will run her ninth consecutive Boston Marathon on April 18th! This year, she will be running in support of the Ellie Fund, a non-profit organization that provides essential support for those receiving treatment for breast cancer in Massachusetts. Read Dr. Comander’s full interview Read more…